Matches in SemOpenAlex for { <https://semopenalex.org/work/W181840914> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W181840914 endingPage "92" @default.
- W181840914 startingPage "84" @default.
- W181840914 abstract "Three hundred and six patients with low- and intermediate-risk leukaemias undergoing allogeneic BMT between 1980 and March 1996 were studied regarding transplantation-related mortality (TRM), relapse, and leukaemia-free survival (LFS). Among the patients were 262 recipients of marrow from HLA-identical siblings and 44 patients receiving marrow from HLA-A, -B, and -DR identical unrelated donors. Between 1986 and 1993, 153 adult patients received ciprofloxacin continuously during Cy conditioning, but since November 1993 ciprofloxacin has not been given until after Cy treatment. TRM at 5 yr showed an incidence of 30%. Significant risk factors in Cox regression multivariate analysis comprised acute GVHD grades II-IV (p < 0.0001), seropositivity for 3-4 herpes viruses prior to BMT (p = 0.002), intermediate risk disease (p = 0.008), female donor to male recipient (p = 0.015), and a donor age over 17 yr (p = 0.025). The risk of relapse was studied from 90 d after BMT, and the overall 5-yr incidence was 32%. Significant risk factors comprised acute leukaemia, as compared to CML (p = 0.003), total body irradiation (TBI) compared to busulphan treatment (p = 0.011), gram-negative prophylaxis with ciprofloxacin during cyclophosphamide (Cy) conditioning (p = 0.024), GVHD prophylaxis using a combination of methotrexate (MTX) and cyclosporine (CSA), compared to monotherapy (p = 0.037) and absence of chronic GVHD (p = 0.050). The 5-yr probability of relapse in patients receiving ciprofloxacin prophylaxis during Cy conditioning was 40%, compared to 24% in patients not receiving this treatment (p = 0.01). Overall, LFS at 5 yr was 49%. LFS was evaluated from day 30 after BMT until relapse or death of the patient. We found no difference in TRM, relapse or LFS between recipients of HLA-identical sibling or unrelated bone marrow, risk factors significantly associated with an inferior LFS included acute GVHD grades II-IV (p = 0.0002), intermediate risk disease (p = 0.003), donor seropositivity for 3-4 herpes viruses (p = 0.046), and TBI conditioning (p = 0.048)." @default.
- W181840914 created "2016-06-24" @default.
- W181840914 creator A5038362533 @default.
- W181840914 creator A5043488712 @default.
- W181840914 creator A5049878797 @default.
- W181840914 creator A5065745451 @default.
- W181840914 creator A5079082437 @default.
- W181840914 creator A5080055664 @default.
- W181840914 creator A5081594057 @default.
- W181840914 date "1998-04-01" @default.
- W181840914 modified "2023-10-03" @default.
- W181840914 title "Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination." @default.
- W181840914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9575394" @default.
- W181840914 hasPublicationYear "1998" @default.
- W181840914 type Work @default.
- W181840914 sameAs 181840914 @default.
- W181840914 citedByCount "6" @default.
- W181840914 countsByYear W1818409142013 @default.
- W181840914 crossrefType "journal-article" @default.
- W181840914 hasAuthorship W181840914A5038362533 @default.
- W181840914 hasAuthorship W181840914A5043488712 @default.
- W181840914 hasAuthorship W181840914A5049878797 @default.
- W181840914 hasAuthorship W181840914A5065745451 @default.
- W181840914 hasAuthorship W181840914A5079082437 @default.
- W181840914 hasAuthorship W181840914A5080055664 @default.
- W181840914 hasAuthorship W181840914A5081594057 @default.
- W181840914 hasConcept C120665830 @default.
- W181840914 hasConcept C121332964 @default.
- W181840914 hasConcept C126322002 @default.
- W181840914 hasConcept C141071460 @default.
- W181840914 hasConcept C207103383 @default.
- W181840914 hasConcept C2776694085 @default.
- W181840914 hasConcept C2776755627 @default.
- W181840914 hasConcept C2778461978 @default.
- W181840914 hasConcept C2778512257 @default.
- W181840914 hasConcept C2778880498 @default.
- W181840914 hasConcept C2781059491 @default.
- W181840914 hasConcept C2781107101 @default.
- W181840914 hasConcept C2909962599 @default.
- W181840914 hasConcept C2911091166 @default.
- W181840914 hasConcept C44249647 @default.
- W181840914 hasConcept C501593827 @default.
- W181840914 hasConcept C50382708 @default.
- W181840914 hasConcept C61511704 @default.
- W181840914 hasConcept C71924100 @default.
- W181840914 hasConcept C86803240 @default.
- W181840914 hasConcept C89423630 @default.
- W181840914 hasConcept C90924648 @default.
- W181840914 hasConceptScore W181840914C120665830 @default.
- W181840914 hasConceptScore W181840914C121332964 @default.
- W181840914 hasConceptScore W181840914C126322002 @default.
- W181840914 hasConceptScore W181840914C141071460 @default.
- W181840914 hasConceptScore W181840914C207103383 @default.
- W181840914 hasConceptScore W181840914C2776694085 @default.
- W181840914 hasConceptScore W181840914C2776755627 @default.
- W181840914 hasConceptScore W181840914C2778461978 @default.
- W181840914 hasConceptScore W181840914C2778512257 @default.
- W181840914 hasConceptScore W181840914C2778880498 @default.
- W181840914 hasConceptScore W181840914C2781059491 @default.
- W181840914 hasConceptScore W181840914C2781107101 @default.
- W181840914 hasConceptScore W181840914C2909962599 @default.
- W181840914 hasConceptScore W181840914C2911091166 @default.
- W181840914 hasConceptScore W181840914C44249647 @default.
- W181840914 hasConceptScore W181840914C501593827 @default.
- W181840914 hasConceptScore W181840914C50382708 @default.
- W181840914 hasConceptScore W181840914C61511704 @default.
- W181840914 hasConceptScore W181840914C71924100 @default.
- W181840914 hasConceptScore W181840914C86803240 @default.
- W181840914 hasConceptScore W181840914C89423630 @default.
- W181840914 hasConceptScore W181840914C90924648 @default.
- W181840914 hasIssue "2" @default.
- W181840914 hasLocation W1818409141 @default.
- W181840914 hasOpenAccess W181840914 @default.
- W181840914 hasPrimaryLocation W1818409141 @default.
- W181840914 hasRelatedWork W2015335289 @default.
- W181840914 hasRelatedWork W2018315087 @default.
- W181840914 hasRelatedWork W2055039546 @default.
- W181840914 hasRelatedWork W2074695959 @default.
- W181840914 hasRelatedWork W2264531153 @default.
- W181840914 hasRelatedWork W2338831075 @default.
- W181840914 hasRelatedWork W2408436110 @default.
- W181840914 hasRelatedWork W2415677002 @default.
- W181840914 hasRelatedWork W2538699508 @default.
- W181840914 hasRelatedWork W2580944945 @default.
- W181840914 hasVolume "12" @default.
- W181840914 isParatext "false" @default.
- W181840914 isRetracted "false" @default.
- W181840914 magId "181840914" @default.
- W181840914 workType "article" @default.